BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

MetaVia Inc. – Material Contracts

NASDAQ: MTVA    
Share price (8/7/26): $1.49    
Market cap (8/7/26): $9.816 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 8 pages MetaVia Inc. Amended and Restated Non-Employee Director Compensation Policy ​ Effective Date: May 7, 2024; as Amended on November 29, 2024 and June 8, 2026
12/34/56
EX-10.1
from 8-K 1 page First Amendment to the MetaVia Inc. Amended and Restated 2022 Equity Incentive Plan Recitals
12/34/56
EX-10.3
from 10-K 2 pages Material contract
12/34/56
EX-10.3
from 8-K 24 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 10 pages Placement Agency Agreement May 8, 2025
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.9
from 10-K 8 pages MetaVia Inc. Amended and Restated Non-Employee Director Compensation Policy ​ Effective Date: May 7, 2024; as Amended November 29, 2024
12/34/56
EX-10.7
from 10-K 60 pages MetaVia Inc. Amended and Restated 2022 Equity Incentive Plan Adopted by the Board of Directors: November 8, 2022 Approved by the Stockholders: December 22, 2022 Amended by the Board of Directors: November 29, 2024
12/34/56
EX-10.6
from 10-K 37 pages MetaVia Inc. Amended and Restated 2021 Inducement Plan Adopted by the Board of Directors: November 3, 2021 Amended by the Board of Directors: November 29, 2024
12/34/56
EX-10.5
from 10-K 56 pages Gemphire Therapeutics Inc. 2019 Equity Incentive Plan
12/34/56
EX-10.1
from 10-K 13 pages Agreement
12/34/56
EX-10.3
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages ​ First Amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 8 pages NeuroBo Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy ​ Effective Date: May 7, 2024
12/34/56
EX-10.1
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 27 pages Alewife Properties LLC Standard Form Lease
12/34/56
EX-10.1
from 8-K 21 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 9 pages NeuroBo Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy ​ Effective Date: June 27, 2023
12/34/56